Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identification of Potential Biomarkers in Prostate Cancer Microarray Gene Expression Leveraging Explainable Machine Learning Classifiers.

Cancers·2025
Same author

Integrating Multi-Omics and Medical Imaging in Artificial Intelligence-Based Cancer Research: An Umbrella Review of Fusion Strategies and Applications.

Cancers·2025
Same author

Leveraging Machine Learning for Severity Level-Wise Biomarker Identification in Prostate Cancer Microarray Gene Expression Data.

Biomedicines·2025
Same author

Investigating the impact of social media images on users' sentiments towards sociopolitical events based on deep artificial intelligence.

PloS one·2025
Same author

LSTM-driven drug design using SELFIES for target-focused de novo generation of HIV-1 protease inhibitor candidates for AIDS treatment.

PloS one·2024
Same author

Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning.

Cancers·2023

相关实验视频

Updated: Jan 11, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

轻量级深度学习模型与可解释的AI用于从标准MRI扫描中检测早期阿尔茨海默氏症.

Falah Sheikh1, Ahmed Al Marouf1, Jon George Rokne1

  • 1Department of Computer Science, University of Calgary, Calgary, AB T2N 1N4, Canada.

Diagnostics (Basel, Switzerland)
|November 13, 2025
PubMed
概括

这项研究开发了轻量级的深度学习模型,用于使用MRI扫描进行早期阿尔茨海默病 (AD) 检测. EfficientNetV2B0模型实现了88%的准确性,为临床诊断提供了一个易于使用的工具.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.有效的NetV2B0,移动的NetV2深度学习是一种深度学习.

更多相关视频

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

相关实验视频

Last Updated: Jan 11, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

科学领域:

  • 神经成像是一种神经成像.
  • 人工智能的人工智能
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 痴呆症,包括阿尔茨海默氏症 (AD),影响全球数百万人,在资源有限的环境中,诊断具有挑战性.
  • 目前阿尔茨海默病的诊断方法通常依赖于昂贵的神经成像和专家专业知识,阻碍了早期检测.
  • 早期诊断AD对于管理症状和减缓疾病进展至关重要.

研究的目的:

  • 开发和评估计算效率高的深度学习模型,用于早期发现阿尔茨海默病.
  • 为应对临床实践中易于及时诊断AD的挑战.
  • 为了提高AI模型在神经成像中的可解释性,以获得临床信任.

主要方法:

  • 使用了轻量级的深度学习模型,MobileNetV2和EfficientNetV2B0.0.
  • 在2D结构磁共振成像 (MRI) 片上训练模型,用于早期AD检测.
  • 应用可解释性方法 (Grad-CAM++,Guided Grad-CAM++) 用于模型的可解释性.

主要成果:

  • EfficientNetV2B0模型在区分认知正常 (CN),早期轻度认知障碍 (EMCI) 和晚期轻度认知障碍 (LMCI) 方面实现了88.0%的平均准确率.
  • 该模型在多类分类任务中表现出强的表现.
  • 可解释性方法成功地可视化了影响模型预测的解剖区域.

结论:

  • 开发了一个可访问和可解释的神经成像工具,用于早期AD诊断.
  • 拟议的深度学习模型可以将专家级的诊断能力扩展到常规的临床环境.
  • 这种方法促进了早期干预和阿尔茨海默病的管理.